TRCT
EXAS

Tower Research Capital (TRC)’s Exact Sciences EXAS Stock Holding History

Tower Research Capital (TRC)’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-176
Closed -$17.9K – 5229
2025
Q4 		$17.9K Sell
176
-16,593
-99% -$1.33M ﹤0.01% 3186
2025
Q3 		$917K Buy
16,769
+14,903
+799% +$745K 0.03% 551
2025
Q2 		$99.2K Sell
1,866
-7,395
-80% -$376K ﹤0.01% 2382
2025
Q1 		$401K Sell
9,261
-3,588
-28% -$182K 0.01% 966
2024
Q4 		$722K Buy
12,849
+11,745
+1,064% +$731K 0.01% 831
2024
Q3 		$75.2K Sell
1,104
-33,870
-97% -$1.91M ﹤0.01% 2462
2024
Q2 		$1.48M Buy
34,974
+29,719
+566% +$1.64M 0.02% 549
2024
Q1 		$363K Sell
5,255
-161
-3% -$10.2K 0.01% 1053
2023
Q4 		$401K Buy
5,416
+4,767
+735% +$312K ﹤0.01% 1552
2023
Q3 		$44.3K Sell
649
-4,544
-88% -$386K ﹤0.01% 2650
2023
Q2 		$488K Sell
5,193
-11,595
-69% -$905K 0.02% 1000
2023
Q1 		$1.14M Buy
16,788
+16,167
+2,603% +$1.04M 0.04% 382
2022
Q4 		$31K Sell
621
-60,466
-99% -$2.47M ﹤0.01% 2711
2022
Q3 		$1.99M Buy
61,087
+49,334
+420% +$2.03M 0.03% 425
2022
Q2 		$463K Buy
11,753
+7,611
+184% +$407K 0.01% 1185
2022
Q1 		$289K Sell
4,142
-1,005
-20% -$73.5K ﹤0.01% 1486
2021
Q4 		$400K Buy
5,147
+756
+17% +$66.7K 0.01% 1268
2021
Q3 		$419K Buy
4,391
+3,989
+992% +$421K 0.01% 1124
2021
Q2 		$50K Sell
402
-33,022
-99% -$3.94M ﹤0.01% 3022
2021
Q1 		$4.41M Buy
33,424
+20,758
+164% +$2.84M 0.07% 241
2020
Q4 		$1.68M Buy
12,666
+6,750
+114% +$816K 0.05% 276
2020
Q3 		$603K Buy
5,916
+5,664
+2,248% +$489K 0.01% 1476
2020
Q2 		$22K Buy
+252
New +$20.1K ﹤0.01% 3625
2020
Q1 		– Sell
-410
Closed -$38K – 3273
2019
Q4 		$38K Sell
410
-1,279
-76% -$112K ﹤0.01% 1508
2019
Q3 		$153K Buy
+1,689
New +$192K 0.01% 1129
2019
Q2 		– Sell
-55
Closed -$5K – 3855
2019
Q1 		$5K Buy
55
+23
+72% +$1.96K ﹤0.01% 3049
2018
Q4 		$2K Sell
32
-911
-97% -$62.5K ﹤0.01% 3348
2018
Q3 		$74K Sell
943
-3,442
-78% -$224K 0.01% 1524
2018
Q2 		$262K Buy
+4,385
New +$236K 0.01% 944
2017
Q4 		– Sell
-7,196
Closed -$339K – 3650
2017
Q3 		$339K Buy
+7,196
New +$290K 0.03% 422
2017
Q1 		– Sell
-15,553
Closed -$208K – 3279
2016
Q4 		$208K Buy
15,553
+15,236
+4,806% +$246K 0.02% 613
2016
Q3 		$6K Buy
+317
New +$5.59K ﹤0.01% 2413
2016
Q2 		– Sell
-745
Closed -$5K – 4565
2016
Q1 		$5K Buy
745
+102
+16% +$653 ﹤0.01% 2676
2015
Q4 		$6K Buy
643
+578
+889% +$5.37K ﹤0.01% 2757
2015
Q3 		$1K Sell
65
-1,786
-96% -$41K ﹤0.01% 3597
2015
Q2 		$55K Sell
1,851
-17,252
-90% -$433K ﹤0.01% 1288
2015
Q1 		$421K Buy
19,103
+18,709
+4,748% +$475K 0.05% 196
2014
Q4 		$11K Sell
394
-3,497
-90% -$85.1K ﹤0.01% 2055
2014
Q3 		$75K Buy
3,891
+3,841
+7,682% +$70.4K 0.01% 1206
2014
Q2 		$1K Buy
+50
New +$688 ﹤0.01% 3652
2014
Q1 		– Sell
-13,634
Closed -$160K – 4584
2013
Q4 		$160K Buy
13,634
+9,986
+274% +$115K 0.03% 619
2013
Q3 		$43K Buy
+3,648
New +$46.8K ﹤0.01% 2043

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Tower Research Capital (TRC)'s EXAS Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 176 shares — an estimated $17.9K sold.

Tower Research Capital (TRC) first reported a position in EXAS in Q3 2013 and held it in 42 quarters. The position peaked at $4.41M in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 176 Exact Sciences shares in Q1 2026, an estimated $17.9K.
  • Tower Research Capital (TRC) first reported a position in Exact Sciences in Q3 2013 and held it in 42 quarters.
  • Tower Research Capital (TRC)'s Exact Sciences position peaked at $4.41M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.